°¡Å縯´ëÇб³¼¿ï¼º¸ðº´¿ø 2023 Catholic Hematology Hospital Symposium ¡°A new paradigm for hematologic diseases¡± : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : 2023 Catholic Hematology Hospital Symposium ¡°A new paradigm for hematologic diseases¡±
ÁÖÃÖ±â°ü : °¡Å縯´ëÇб³¼¿ï¼º¸ðº´¿ø
´ã´çÀÚ : ±èµµÈ
¿¬¶ôó : 02-2258-3005
À̸ÞÀÏ : d@cmcnu.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 12:40~12:50 Registration ()
±âŸ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 12:50~13:10 Opening remarks & HSCT history of Catholic Hematology Hospital ±èÈñÁ¦(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 13:10~13:30 Part 1: Allogeneic HSCT À±ÀçÈ£(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
Åä·Ð 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 13:30~14:10 Panel Discussion ÀÌÁ¾¿í À±¼º¼ö ±èµ¿¿í ¼Õ»ó±Õ Á¶ºó ÀÌÁ¦È¯ À̼® °ÇüÁø(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ¼¿ï´ëÇб³º´¿ø ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø °æºÏ´ëÇб³º´¿ø °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ¼¿ï¾Æ»êº´¿ø °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 14:10~14:30 Part 2: Autologous HSCT ¹Ú¼º¼ö(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
Åä·Ð 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 14:30~15:10 Panel Discussion ¹Îâ±â ¾öÇö¼® ÀÌÁ¦Áß ±¹ÈÆ ¼º±â¿õ Á¤³«±Õ ¾ö±â¼º ±è¼®Áø(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ±¹¸³¾Ï¼¾ÅÍ Àü³²´ëÇб³º´¿ø Àü³²´ëÇб³º´¿ø »ï¼º¼¿ïº´¿ø °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø »ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 15:10~15:25 ÈÞ½Ä ()
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 15:25~15:50 Strategies to reduce relapse after post-allogeneic HSCT in AML/MDS Á¤ÁØ¿ø(½ÅÃ̼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 15:50~16:15 Antibody-based therapy for allogeneic HSCT in ALL ½ÅÈ£Áø(ºÎ»ê´ëÇб³º´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 16:15~16:40 Evolving treatment strategies in RRMM ±è¼ºÇö(µ¿¾Æ´ëÇб³º´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 16:40~17:05 Immune therapies for lymphoid malignancies ÀÌÀç¿í(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
ÈÞ½Ä 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 17:05~17:15 ÈÞ½Ä ()
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 17:15~17:30 Near-New preventive and therapeutic options in infectious diseases À̵¿°Ç(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 17:30~17:45 Management of pulmonary complications ÀÌÁø±¹(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04-14 ¿È´Ï¹ö½ºÆÄÅ© B3[Lobby] ÄÁº¥¼ÇȦ 17:45~18:00 How can we reduce liver-related morbidity and mortality in patients after HSCT ¼ºÇʼö(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)